{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:41Z","timestamp":1793136941360,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T00:00:00Z","timestamp":1418428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00108-014-3613-8","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T13:43:01Z","timestamp":1418391781000},"page":"41-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["ANCA-assoziierte Vaskulitiden","ANCA-associated vasculitis"],"prefix":"10.1007","volume":"56","author":[{"given":"J.U.","family":"Holle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"key":"3613_CR1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","volume":"33","author":"Fries","year":"1990","unstructured":"Fries JF, Hunder GG, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum 33:1135\u20131136","journal-title":"Arthritis Rheum"},{"key":"3613_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"3613_CR3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"3613_CR4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg Strauss syndrome (Allergic Granulomatosis and angiitis). Arthritis Rheum 33:1094\u20131100","journal-title":"Arthritis Rheum"},{"key":"3613_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.20928","volume":"53","author":"Reinhold-Keller","year":"2005","unstructured":"Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R et al (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis registry. Arthritis Rheum 53:93\u201399","journal-title":"Arthritis Rheum"},{"key":"3613_CR6","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"Jayne","year":"2007","unstructured":"Jayne DR, Gaskin G, Rasmussen N et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18:2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"3613_CR7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody associated vasculitis: a meta-analysis. Ann Rheum Dis 72:1003\u20131010","journal-title":"Ann Rheum Dis"},{"key":"3613_CR8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","volume":"66","author":"Hellmich","year":"2007","unstructured":"Hellmich B, Flossmann O, Gross WL et al (2007) EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66:605\u2013617","journal-title":"Ann Rheum Dis"},{"key":"3613_CR9","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"Hiemstra","year":"2010","unstructured":"Hiemstra TF, Walsh M, Mahr A et al (2010) Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 304:2381\u20132388","journal-title":"JAMA"},{"key":"3613_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","volume":"65","author":"Comarmond","year":"2013","unstructured":"Comarmond C, Pagnoux C, Khellaf M et al (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) \u2013 clinical characteristics and long-term follow-up oft he 383 patients enrolled in the FVSG cohort. Arthritis Rheum 65:270\u2013281","journal-title":"Arthritis Rheum"},{"key":"3613_CR11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","volume":"72","author":"Moosig","year":"2013","unstructured":"Moosig F, Bremer JP, Hellmich B et al (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis with polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72:1011\u20131017","journal-title":"Ann Rheum Dis"},{"key":"3613_CR12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","unstructured":"Sabl\u00e9-Fourtassou R, Cohen P, Mahr A et al (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143:623\u2013638","journal-title":"Ann Intern Med"},{"key":"3613_CR13","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"Sinico","year":"2005","unstructured":"Sinico RA, Di Toma L, Maggiore U et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52:2926\u20132935","journal-title":"Arthritis Rheum"},{"key":"3613_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6","volume":"42","author":"Guillevin","year":"1999","unstructured":"Guillevin L, Durand-Gasselin B, Cevallos R et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421\u2013430","journal-title":"Arthritis Rheum"},{"key":"3613_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","volume":"63","author":"Holle","year":"2011","unstructured":"Holle JU, Gross WL, Latza U et al (2011) Improved outcome in 445 patients with Wegener\u2019s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63:257\u2013266","journal-title":"Arthritis Rheum"},{"key":"3613_CR16","doi-asserted-by":"crossref","unstructured":"Bourgarit A, Le Toumelin P, Pagnoux C et al (2005) Deaths occurring during the first year after treatment onset for polyarteriitis nodosa, microscopic polyangiitis and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 84:323\u2013330","DOI":"10.1097\/01.md.0000180793.80212.17"},{"key":"3613_CR17","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"Guillevin","year":"2014","unstructured":"Guillevin L, Pagnoux C, Karras A et al (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"3613_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-155-5-201109060-00026","volume":"155","author":"Moosig","year":"2011","unstructured":"Moosig F, Gross WL, Herrmann K et al (2011) Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome. Ann Intern Med 155:341\u2013343","journal-title":"Ann Intern Med"},{"key":"3613_CR19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"Savige","year":"1999","unstructured":"Savige J, Gillis D, Benson E et al (1999) International consensus statement on testing and reporting of Antineutrophil Cytoplasmatic Antibodies (ANCA). Am J Clin Pathol 111:507\u2013513","journal-title":"Am J Clin Pathol"},{"key":"3613_CR20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"3613_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0b013e32834d85ce","volume":"24","author":"Vaglio","year":"2012","unstructured":"Vaglio A, Moosig F, Zwerina J (2012) Churg-Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol 24:24\u201330","journal-title":"Curr Opin Rheumatol"},{"key":"3613_CR22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"3613_CR23","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","volume":"359","author":"Pagnoux","year":"2008","unstructured":"Pagnoux C, Mahr A, Hamidou MA et al (2008) Azathioprine or methotrexate for ANCA-associated vasculitis. N Engl J Med 359:2790\u20132803","journal-title":"N Engl J Med"},{"key":"3613_CR24","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1136\/ard.2010.130203","volume":"69","author":"Holle","year":"2010","unstructured":"Holle JU, Gross WL, Holl-Ulrich K et al (2010) Prospective long-term follow-up of patients with localised Wegener\u2019s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69:1934\u20131939","journal-title":"Ann Rheum Dis"},{"key":"3613_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2013.131","volume":"84","author":"Walsh","year":"2013","unstructured":"Walsh M, Casian A, Flossman O et al (2013) Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear. Kidney Int 84:397\u2013402","journal-title":"Kidney Int"},{"key":"3613_CR26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","volume":"69","author":"Little","year":"2012","unstructured":"Little MA, Nightingale P, Verburgh CA et al (2012) Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 69:1036\u20131043","journal-title":"Ann Rheum Dis"},{"key":"3613_CR27","first-page":"S52","volume":"22","author":"Metzler","year":"2004","unstructured":"Metzler C, Hellmich B, Gause A et al (2004) Churg Strauss syndrome \u2013 successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol 22(6 Suppl 36):S52\u2013S61","journal-title":"Clin Exp Rheumatol"},{"key":"3613_CR28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/art.23198","volume":"58","author":"Ribi","year":"2008","unstructured":"Ribi C, Cohen P, Mahr A et al (2008) Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized open-label study of seventy-two patients. Arthritis Rheum 58:586\u2013594","journal-title":"Arthritis Rheum"},{"key":"3613_CR29","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/art.22679","volume":"57","author":"Cohen","year":"2007","unstructured":"Cohen P, Pagnoux C, Mahr A et al (2007) Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cycloposphamide pulses in forty-eight patients. Arthritis Rheum 57:676\u2013693","journal-title":"Arthritis Rheum"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-014-3613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-014-3613-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T04:17:40Z","timestamp":1558585060000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-014-3613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3613"],"URL":"https:\/\/doi.org\/10.1007\/s00108-014-3613-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]}}}